Posted by: cancervisa | January 18, 2008
yikes!
| The Wall Street Journal on Friday examined the efficacy of two diagnostic tests used to determine which drugs to prescribe women with invasive breast cancer. According to the Journal, thousands of women with breast cancer might be receiving the wrong treatment because of errors in the two tests predominantly used to determine which drugs to prescribe. |
| Thousands of breast cancer patients might receive improper medications as a result of inaccurate results for two laboratory tests used to determine the most effective treatments for specific patients, the Wall Street Journal reports. |
Posted in breast cancer, cancer, cancer survivor, chemotherapy, life, living with cancer | Tags: 5FU, Blogroll, Breast cancer premenopausal, breast cancer survival, chemotherapy, health, Paxol, Taxol, treatments advanced
cancervisa